FIELD: medicine.
SUBSTANCE: what is presented is using H1.3 recombinant histone protein as an eukaryotic cell adenoviral transduction inhibitor. The invention can be used to producing drug preparations for the diseases related to adenoviral infection.
EFFECT: higher clinical effectiveness.
2 dwg, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DELIVERY OF NUCLEINIC ACIDS INTO EUKARYOTIC CELLS | 2014 |
|
RU2563804C1 |
| ADENOVIRUS CONTAINING ALBUMIN-BINDING SITE | 2015 |
|
RU2711371C2 |
| EFFECTIVE AND BALANCED BIDIRECTIONAL PROMOTER | 2017 |
|
RU2758238C2 |
| METHOD FOR PROVIDING HIGHER EFFECTIVENESS OF VIRAL TRANSDUCTION | 2011 |
|
RU2478711C1 |
| EFFICIENT AND BALANCED BIDIRECTIONAL PROMOTOR | 2017 |
|
RU2745500C2 |
| CODON-OPTIMISED CDNA CODING HUMAN DYSFERLIN, GENETICALLY ENGINEERED CONSTRUCT, RECOMBINANT ADENOVIRUS AND PHARMACEUTICAL COMPOSITION FOR TREATING DYSFERLINOPATHIES | 2012 |
|
RU2527073C2 |
| GENETIC VECTOR Ad6/3-hTERT-GMCSF CONTAINING GENOMIC SEQUENCES OF RECOMBINANT ADENOVIRUS SEROTYPE 6, HUMAN TELOMERASE PROMOTER, HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR GENE, AS WELL AS FIBER PROTEIN GENE WITH INSERTION OF FIBER KNOB DOMAIN OF ADENOVIRUS SEROTYPE 3 WITH INCREASED TRANSDUCTION INTO TUMOR CELLS | 2023 |
|
RU2814581C1 |
| COMPOSITION FOR AMPLIFICATION OF TRANSGENE EXPRESSION IN EUCARIOTIC CELLS, AND METHOD FOR INCREASING GENERATION OF TARGET PROTEIN CODED WITH TRANSGENE | 2013 |
|
RU2546249C2 |
| IMMUNOBIOLOGICAL AGENT AND A METHOD FOR USE THEREOF FOR INDUCING SPECIFIC IMMUNITY TO THE MIDDLE EASTERN RESPIRATORY SYNDROME VIRUS (VERSIONS) | 2018 |
|
RU2709659C1 |
| METHOD FOR STIMULATING SPINAL CORD REGENERATION WITH GENETICALLY MODIFIED HUMAN UMBILICAL CORD BLOOD CELLS | 2013 |
|
RU2521225C2 |
